Pancreatic Cancer: Are ‘Targeted Inhibitor’ Developed by Israeli and Japanese Scientists New Hope?
20 Oct 2024 13:45 PM IST
The research, a collaborative effort involving the Hebrew University of Jerusalem, the Weizmann Institute of Science, and the University of Tokyo, represents a major breakthrough in targeting an enzyme called Matrix Metallopeptidase 7 (MMP7) which facilitates the invasion of cancer cells into surrounding tissues.
